Differentiation of human pluripotent stem cells to cardiomyocytes under defined conditions

Methods in Molecular Biology

Volumn 1353, Issue , 2014, Pages 163-180

  Van Den Berg, Cathelijne W ^a   Elliott, David A ^a   Braam, Stefan R ^a   Mummery, Christine L ^a   Davis, Richard P ^a  

^a NONE

Author keywords

Cardiac differentiation; Cardiomyocyte characterization; Human embryonic stem cells; Human induced pluripotent stem cells

Indexed keywords

CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; FETAL CALF SERUM; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PLURIPOTENT STEM CELL; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MOLECULAR IMAGING; NUCLEAR REPROGRAMMING; PRIMARY CELL CULTURE; PROCEDURES;

6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; 7,8 DIHYDRO 2 [4 (TRIFLUOROMETHYL)PHENYL] 5H THIOPYRANO[4,3 D]PYRIMIDIN 4 OL; ACTIVIN; ACTIVIN A; BIOLOGICAL MARKER; BMP4 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN; DRUG COMBINATION; ENZYME INHIBITOR; FUSED HETEROCYCLIC RINGS; LAMININ; MATRIGEL; PROTEOGLYCAN; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SIGNAL PEPTIDE; TNNT2 PROTEIN, HUMAN; TROPONIN T;

ACTIVINS; BIOMARKERS; BONE MORPHOGENETIC PROTEIN 4; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; COLLAGEN; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; ENZYME INHIBITORS; GENE EXPRESSION; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MOLECULAR IMAGING; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; PRIMARY CELL CULTURE; PROTEOGLYCANS; PYRIDINES; PYRIMIDINES; TROPONIN T;

EID: 84946753791     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_178     Document Type: Chapter

References (27)

1. Davis RP, van den Berg CW, Casini S et al (2011) Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 17(9): 475-484
2. Moretti A, Laugwitz KL, Dorn T et al (2013) Pluripotent stem cell models of human heart disease. Cold Spring Harb Perspect Med 3 (11):1-11
3. Sterneckert JL, Reinhardt P, Scholer HR (2014) Investigating human disease using stem cell models. Nat Rev Genet 15(9): 625-639
4. Davis RP, Casini S, van den Berg CW et al (2012) Cardiomyocytes derived from pluripo-tent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 125 (25):3079-3091
5. Bellin M, Casini S, Davis RP et al (2013) Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J 32(24):3161-3175
6. Mummery C, Ward-van Oostwaard D, Doe-vendans P et al (2003) Differentiation of human embryonic stem cells to cardiomyo-cytes: role of coculture with visceral.M. Endoderm-like cells. Circulation 107(21): 2733-2740
7. Mummery CL, Zhang J, Ng ES et al (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardio-myocytes: a methods overview. Circ Res 111 (3):344-358
8. Elliott DA, Braam SR, Koutsis K et al (2011) NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyo-cytes. Nat Methods 8(12):1037-1040
9. Ng ES, Davis R, Stanley EG et al (2008) A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 3(5):768-776
10. Ungrin MD, Joshi C, Nica A et al (2008) Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 3(2): e1565
11. Bauwens CL, Song H, Thavandiran N et al (2011) Geometric control of cardiomyogenic induction in human pluripotent stem cells. Tissue Eng Part A 17(15-16):1901-1909
12. Lian X, Hsiao C, Wilson G et al (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 109(27):E1848-E1857
13. Burridge PW, Matsa E, Shulda P et al (2014) Chemically defined generation of human cardiomyocytes. Nat Methods 11(8):855-860
14. Chong JJ, Yang X, Don CW et al (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510(7504):273-277
15. Paige SL, Osugi T, Afanasiev OK et al (2010) Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5(6):e11134
16. Dambrot C, Buermans HP, Varga E et al (2014) Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripo-tent stem cell clones. Exp Cell Res 327 (2):297-306
17. Den Hartogh SC, Schreurs C, Monshouwer-Kloots JJ et al (2015) Dual reporter MESP1 (mCherry/w)-NKX2-5(eGFP/w) hESCs enable studying early human cardiac differentiation. Stem Cells 33(1):56-67
18. Costa M, Sourris K, Hatzistavrou T et al (2008) Expansion of human embryonic stem cells in vitro. Curr Protoc Stem Cell Biol 5 (C):1C.1.1-1C.1.7
19. Chen G, Gulbranson DR, Hou Z et al (2011) Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8(5): 424-429
20. Skelton RJ, Costa M, Anderson DJ et al (2014) SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res 13(1):172-179
21. Watanabe K, Ueno M, Kamiya D et al (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25(6):681-686
22. Braam SR, Nauw R, Ward-van Oostwaard D et al (2010) Inhibition of ROCK improves survival of human embryonic stem cell-derived cardiomyocytes after dissociation. Ann N Y Acad Sci 1188:52-57
23. Chetty S, Pagliuca FW, Honore C et al (2013) A simple tool to improve pluripotent stem cell differentiation. Nat Methods 10 (6):553-556
24. Kattman SJ, Witty AD, Gagliardi M et al (2011) Stage-specific optimization of activin/ nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripo-tent stem cell lines. Cell Stem Cell 8(2): 228-240
25. Anderson D, Self T, Mellor IR et al (2007) Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 15(11):2027-2036
26. Huber I, Itzhaki I, Caspi O et al (2007) Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J 21(10):2551-2563
27. Bu L, Jiang X, Martin-Puig S et al (2009) Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460(7251):113-117